4//SEC Filing
Ashe Andrew D. 4
Accession 0000950170-24-060613
CIK 0001840574other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:30 PM ET
Size
4.9 KB
Accession
0000950170-24-060613
Insider Transaction Report
Form 4
Ashe Andrew D.
See Remarks
Transactions
- Purchase
Common Stock
2024-05-14$6.26/sh+76,000$475,760→ 342,509 total
Footnotes (1)
- [F1]Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $6.22 to $6.30 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Verve Therapeutics, Inc.
CIK 0001840574
Entity typeother
Related Parties
1- filerCIK 0001573163
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:30 PM ET
- Size
- 4.9 KB